Phenotype and genotype characteristics of children with cardiomyopathy associated with MYH7 gene mutation: a retrospective analysis.
10.7499/j.issn.1008-8830.2306108
- Author:
Lu LIU
1
;
Kui ZHENG
;
Ying-Qian ZHANG
Author Information
1. Department of Cardiology, Hebei Children's Hospital/Hebei Province Key Laboratory of Pediatric Cardiovascular Disease, Shijiazhuang 050031, China.
- Publication Type:Journal Article
- Keywords:
Child;
Dilated cardiomyopathy;
Hypertrophic cardiomyopathy;
MYH7 gene;
Mutation
- MeSH:
Male;
Female;
Child;
Humans;
Retrospective Studies;
Cardiomyopathy, Dilated/genetics*;
Pedigree;
Phenotype;
Genotype;
Mutation;
Cardiomyopathy, Hypertrophic/diagnosis*;
Myosin Heavy Chains/genetics*;
Cardiac Myosins/genetics*
- From:
Chinese Journal of Contemporary Pediatrics
2023;25(11):1156-1160
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To investigate the clinical phenotype and genotype characteristics of children withcardiomyopathy (CM) associated with MYH7 gene mutation.
METHODS:A retrospective analysis was conducted on the medical data of five children with CM caused by MYH7 gene mutation who were diagnosed and treated in the Department of Cardiology, Hebei Children's Hospital.
RESULTS:Among the five children with CM, there were three girls and two boys, all of whom carried MYH7 gene mutation. Seven mutation sites were identified, among which five were not reported before. Among the five children, there were three children with hypertrophic cardiomyopathy, one child with dilated cardiomyopathy, and one child with noncompaction cardiomyopathy. The age ranged from 6 to 156 months at the initial diagnosis. At the initial diagnosis, two children had the manifestations of heart failure such as cough, shortness of breath, poor feeding, and cyanosis of lips, as well as delayed development; one child had palpitation, blackness, and syncope; one child had fever, runny nose, and abnormal liver function; all five children had a reduction in activity endurance. All five children received pharmacotherapy for improving cardiac function and survived after follow-up for 7-24 months.
CONCLUSIONS:The age of onset varies in children with CM caused by MYH7 gene mutation, and most children lack specific clinical manifestations at the initial diagnosis and may have the phenotype of hypertrophic cardiomyopathy, dilated cardiomyopathy or noncompaction cardiomyopathy. The children receiving early genetic diagnosis and pharmacological intervention result in a favorable short-term prognosis.
